BioNexus Gene Lab (BGLC) Amortization of Deferred Charges (2022 - 2026)
BioNexus Gene Lab (BGLC) reported Amortization of Deferred Charges of $15589.0 for Q1 2026, up 16.52% on a YoY basis from $13379.0 in Q1 2025, and up 5.56% sequentially from $14768.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 5 years of Amortization of Deferred Charges data on file, last reported at $15589.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 16.52% year-over-year to $15589.0; the trailing twelve-month figure through Mar 2026 stood at $58644.0 (up 18.73% YoY), and the FY2025 full-year result was $56434.0, up 15.21% from the prior year.
- Amortization of Deferred Charges climbed to $15589.0 in Q1 2026, from $14768.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $15589.0 in Q1 2026 to a low of $3919.0 in Q2 2023.
- A 5-year average of $9898.5 and a median of $13379.0 in 2025 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges retreated 8.5% in 2023 and surged 91.58% in 2024, its largest moves.
- Tracing BGLC's Amortization of Deferred Charges over 5 years: stood at $4168.0 in 2022, then jumped by 85.44% to $7729.0 in 2023, then soared by 74.36% to $13476.0 in 2024, then climbed by 9.59% to $14768.0 in 2025, then climbed by 5.56% to $15589.0 in 2026.
- Business Quant data shows BGLC's Amortization of Deferred Charges at $15589.0 in Q1 2026, $14768.0 in Q4 2025, and $14354.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,589.00 |
| Mar 31, 2026 | 15,589.00 |
| Dec 31, 2025 | 14,768.00 |
| Dec 31, 2025 | 14,768.00 |
| Sep 30, 2025 | 14,354.00 |
| Sep 30, 2025 | 14,354.00 |
| Jun 30, 2025 | 13,933.00 |
| Jun 30, 2025 | 13,933.00 |
| Mar 31, 2025 | 13,379.00 |
| Mar 31, 2025 | 13,379.00 |
| Dec 31, 2024 | 13,476.00 |
| Dec 31, 2024 | 13,476.00 |
| Sep 30, 2024 | 14,807.00 |
| Sep 30, 2024 | 14,807.00 |
| Sep 30, 2023 | 7,729.00 |
| Sep 30, 2023 | 7,729.00 |
| Jun 30, 2023 | 3,919.00 |
| Jun 30, 2023 | 3,919.00 |
| Mar 31, 2023 | 3,972.00 |
| Mar 31, 2023 | 3,972.00 |